Cargando…
Evaluating the Treatment of Diabetic Macular Edema with Aflibercept Based on a Regional Network of Ophthalmologic Care Givers
PURPOSE: In Austria, anti-VEGF therapies are reimbursed only in clinical settings. This study aimed to describe the outcome of a treat and extend regimen (TER) with aflibercept for diabetic macular edema (DME) in a network of practitioners. METHODS: In a prospective study over 36 months, patients wi...
Autores principales: | Khalil, Haidar, Mariacher, Siegfried, Strauss, Rupert, Podkowinski, Dominika, Waser, Klemens, Bolz, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845034/ https://www.ncbi.nlm.nih.gov/pubmed/36660315 http://dx.doi.org/10.1155/2023/3165965 |
Ejemplares similares
-
A Swept source optical coherence tomography angiography study: Imaging artifacts and comparison of non-perfusion areas with fluorescein angiography in diabetic macular edema
por: Podkowinski, Dominika, et al.
Publicado: (2021) -
Aqueous humour cytokine changes during a loading phase of intravitreal ranibizumab or dexamethasone implant in diabetic macular oedema
por: Podkowinski, Dominika, et al.
Publicado: (2019) -
The role of aflibercept in the management of diabetic macular edema
por: Chang, Andrew A, et al.
Publicado: (2015) -
The clinical utility of aflibercept for diabetic macular edema
por: Stewart, Michael W
Publicado: (2015) -
Short‐term effect on the ocular circulation induced by unilateral intravitreal injection of aflibercept in age‐related maculopathy
por: Mursch‐Edlmayr, Anna Sophie, et al.
Publicado: (2019)